Focused On Life

Developing novel therapies for serious diseases

Learn More
Focused On Life Developing novel therapies for serious diseases
Driven By Science Rapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.

Medivation is proud to be a 2014 Top Workplace Learn More
Top Workplaces 2013 and 2014 Bay Area News Group








Latest News

October 30, 2014
Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy Learn More